Modifications of culture conditions determine tumorigenicity in early passage patient-derived human glioblastoma cell lines

Explore related products in the following collection:

Poster Abstracts - C717

ePosters - C717

Related Products

Thumbnail for Beyond Immune Checkpoint: First-in-Class antibody targeting soluble NKG2D ligand sMIC for cancer immunotherapy

Beyond Immune Checkpoint: First-in-Class antibody targeting soluble NKG2D ligand sMIC for cancer immunotherapy

Thumbnail for Cathepsin D inhibitors as potential therapeutics for breast cancer treatment against triple-negative and triple-positive breast cancers

Cathepsin D inhibitors as potential therapeutics for breast cancer treatment against triple-negative and triple-positive breast cancers

Thumbnail for Promotion of immunogenicity using epigenetic modulation and immune checkpoint inhibition in mouse models of breast cancer

Promotion of immunogenicity using epigenetic modulation and immune checkpoint inhibition in mouse models of breast cancer

Thumbnail for β -Alethine, An Immunostimulatory Drug That Synergizes With Anti-PD1 Therapy

β -Alethine, An Immunostimulatory Drug That Synergizes With Anti-PD1 Therapy

Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.